Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12135032rdf:typepubmed:Citationlld:pubmed
pubmed-article:12135032lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12135032lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:12135032lifeskim:mentionsumls-concept:C0009324lld:lifeskim
pubmed-article:12135032lifeskim:mentionsumls-concept:C0036078lld:lifeskim
pubmed-article:12135032lifeskim:mentionsumls-concept:C0127615lld:lifeskim
pubmed-article:12135032lifeskim:mentionsumls-concept:C0017431lld:lifeskim
pubmed-article:12135032lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:12135032lifeskim:mentionsumls-concept:C0600688lld:lifeskim
pubmed-article:12135032lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:12135032lifeskim:mentionsumls-concept:C0259190lld:lifeskim
pubmed-article:12135032lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:12135032lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:12135032lifeskim:mentionsumls-concept:C0681842lld:lifeskim
pubmed-article:12135032pubmed:issue7lld:pubmed
pubmed-article:12135032pubmed:dateCreated2002-7-23lld:pubmed
pubmed-article:12135032pubmed:abstractText5-Aminosalicylate is metabolized in colonic mucosa by N-acetyltransferase 1 (NAT1), and sulfapyridine is metabolized in the liver by N-acetyltransferase 2 (NAT2). Common genetic polymorphisms in these enzymes result in rapid and slow acetylation. We determined the association between NAT1 genotype and response to mesalamine and sulfasalazine, as well as between NAT2 genotype and toxicity to sulfasalazine, in a population-based cohort of patients with ulcerative colitis.lld:pubmed
pubmed-article:12135032pubmed:languageenglld:pubmed
pubmed-article:12135032pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12135032pubmed:citationSubsetIMlld:pubmed
pubmed-article:12135032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12135032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12135032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12135032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12135032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12135032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12135032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12135032pubmed:statusMEDLINElld:pubmed
pubmed-article:12135032pubmed:monthJullld:pubmed
pubmed-article:12135032pubmed:issn0002-9270lld:pubmed
pubmed-article:12135032pubmed:authorpubmed-author:TremaineWilli...lld:pubmed
pubmed-article:12135032pubmed:authorpubmed-author:HarmsenW...lld:pubmed
pubmed-article:12135032pubmed:authorpubmed-author:WeinshilboumR...lld:pubmed
pubmed-article:12135032pubmed:authorpubmed-author:SandbornWilli...lld:pubmed
pubmed-article:12135032pubmed:authorpubmed-author:ZinsmeisterAl...lld:pubmed
pubmed-article:12135032pubmed:authorpubmed-author:TaylorWilliam...lld:pubmed
pubmed-article:12135032pubmed:authorpubmed-author:LoftusEdward...lld:pubmed
pubmed-article:12135032pubmed:authorpubmed-author:O'KaneDennisDlld:pubmed
pubmed-article:12135032pubmed:authorpubmed-author:RicartElenaElld:pubmed
pubmed-article:12135032pubmed:issnTypePrintlld:pubmed
pubmed-article:12135032pubmed:volume97lld:pubmed
pubmed-article:12135032pubmed:ownerNLMlld:pubmed
pubmed-article:12135032pubmed:authorsCompleteYlld:pubmed
pubmed-article:12135032pubmed:pagination1763-8lld:pubmed
pubmed-article:12135032pubmed:dateRevised2010-9-8lld:pubmed
pubmed-article:12135032pubmed:meshHeadingpubmed-meshheading:12135032...lld:pubmed
pubmed-article:12135032pubmed:meshHeadingpubmed-meshheading:12135032...lld:pubmed
pubmed-article:12135032pubmed:meshHeadingpubmed-meshheading:12135032...lld:pubmed
pubmed-article:12135032pubmed:meshHeadingpubmed-meshheading:12135032...lld:pubmed
pubmed-article:12135032pubmed:meshHeadingpubmed-meshheading:12135032...lld:pubmed
pubmed-article:12135032pubmed:meshHeadingpubmed-meshheading:12135032...lld:pubmed
pubmed-article:12135032pubmed:meshHeadingpubmed-meshheading:12135032...lld:pubmed
pubmed-article:12135032pubmed:meshHeadingpubmed-meshheading:12135032...lld:pubmed
pubmed-article:12135032pubmed:meshHeadingpubmed-meshheading:12135032...lld:pubmed
pubmed-article:12135032pubmed:meshHeadingpubmed-meshheading:12135032...lld:pubmed
pubmed-article:12135032pubmed:meshHeadingpubmed-meshheading:12135032...lld:pubmed
pubmed-article:12135032pubmed:meshHeadingpubmed-meshheading:12135032...lld:pubmed
pubmed-article:12135032pubmed:meshHeadingpubmed-meshheading:12135032...lld:pubmed
pubmed-article:12135032pubmed:meshHeadingpubmed-meshheading:12135032...lld:pubmed
pubmed-article:12135032pubmed:meshHeadingpubmed-meshheading:12135032...lld:pubmed
pubmed-article:12135032pubmed:year2002lld:pubmed
pubmed-article:12135032pubmed:articleTitleN-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis.lld:pubmed
pubmed-article:12135032pubmed:affiliationInflammatory Bowel Disease Clinic, Division of Gastroenterology and Hepatology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA.lld:pubmed
pubmed-article:12135032pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:9entrezgene:pubmedpubmed-article:12135032lld:entrezgene
entrez-gene:10entrezgene:pubmedpubmed-article:12135032lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12135032lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12135032lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12135032lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12135032lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12135032lld:pubmed